Houston expert: Rethinking priorities at educational institutions

guest column

With a new year around the corner, students and parents will soon see school rankings released. But there's so much more to consider than what this data shows. Houston education expert shares his own innovative method. Photo via Getty Images

As a new year approaches, it is common to see various school rankings begin to appear in different studies and within various media outlets. Whether they're ranking colleges, high schools or even pre-k schools, these lists have long impacted the decisions families and students make.

That said, most school rankings are one-dimensional, therefore making them unreliable. The most common factor these classifications take into consideration is the rigor of academics and how they correlate to test scores and admissions. However, students are more than solely an academic statistic – they are artists, athletes and creative thinkers.

It is important, at any level, when considering a school to take into account nine key factors, not just one.

Navigating the selection process

There is a systemic issue with associating the quality of an educational experience to a school's name. Many rankings fuel this fire. Parents are often influenced to make decisions off of frivolous premises that deceive them into thinking one school is of better caliber than another. However, in reality, they are doing their child a disservice by not taking into consideration the many other factors that play into school selection.

Location

Distance to home or workplace is still a top factor in deciding which school to target. Although important to consider, many families tend to focus more on other factors aside from convenience alone.

Cost

The average private high school tuition in the Greater Houston area is $25,083 with annual increases on average of 4-6%. Tuition and financial aid play key factors when making the final decision and choosing which schools to add to a list. Final consideration for this is the cost vs benefit analysis.

Legacy

Studies suggest a "legacy" — you, a spouse or older child who previously attending a potential school — is one of the most popular reasons why schools get added to a target list. Although this is a legitimate approach, it is important to be cautious of not imposing a "legacy" onto a student.

Academics

The quality of education can be measured in rigor of classes, expertise of teachers, use of technology and class size. It is important to take into consideration if Honors, AP, and Dual Credit are offered, the percentage of teachers who have advanced degrees, the accessibility to laptops and smart learning devices, and smaller teacher to student ratios.

Athletics

If a student has an affinity for a sport and is genuinely considering playing the sport at a higher level, then it is important to find a balance between a school that has a strong program for that sport and the other factors on the list.

Social

There are three main social components at play in school choice: if students' friends are considering a school, or parents' own social circles influencing the decision, and the non-academic activities offered at a school. It is important to consider the clubs, organizations, leadership and volunteer opportunities offered as these help contribute to college applications down the road.

K-12 school v. 9-12 school

Some students must consider the adaptation curve for starting a high school in which other students had been attending since kindergarten. Due to this, families may consider 9-12 schools as the better option for their students since everyone starts from scratch.

Single-Gender v. Co-Educational

Deciding on the gender composition of a high school depends on a student's personality, confidence, personal preferences, and family values. Students can find success in both types of offerings, but girls especially may thrive in a single gender environment due to the empowering and confidence building structure of most all-girls schools.

College Preparedness

This should be the ultimate reason to go through a well-informed process for school selection. A school should prepare a student for standardized tests, college applications, and scholarship opportunities, and is the clearest cost to benefit factor to consider.

A new way to determine a student's path

In order to decide the best fit for a student it is time to discontinue the age-old practice of selecting an education based on rankings and subjective labels. It is time to usher in a new innovative approach that takes a look at the personality, values, interests, skills, and goals of a student and the various elements that make them unique.

At Firat Education, we run qualitative and quantitative assessments on students which are scenario-based and are used to identify what drives them, what gets them to the next level, and what excites them. This information then allows us to use a weighted scoring system that, dependent on each student, helps quantify the factors that matter most such as college preparedness, academics, athletics, and social.

Additionally, we look at their changing habits whether it be consistency in their values, their interests, and academic strengths. From here, we put it all together to formulate personalized scores that help prioritize the best fit for that individual student.

Utilizing this developed and dynamic approach to choosing a school is the first step in revolutionizing the way we approach schooling and spearheading a new age of innovation in education.

------

Ibrahim Firat, is the chief educational consultant and co-founder of Houston-based Firat Education.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Houston startup recognized for inclusivity on journey to commercialize next-gen therapeutics

future of medicine

A new Houston biotech company won a special award at the 16th Annual SXSW Pitch Award Ceremony earlier this month.

Phiogen, one of 45 companies that competed in nine categories, was the winner for best inclusivity, much to the surprise of the company’s CEO, Amanda Burkhardt.

Burkhardt tells InnovationMap that while she wanted to represent the heavily female patient population that Phiogen seeks to treat, really she just hires the most skilled scientists.

“The best talent was the folks that we have and it ends up being we have three green card holders on our team. As far as ethnicities, we have on our team we have Indian, African-American, Korean, Chinese Pakistani, Moroccan and Hispanic people and that just kind of just makes up the people who helped us on a day-to-day basis,” she explains.

Phiogen was selected out of 670 companies to be in the health and nutrition category at SXSW.

“We did really well, but there was another company that also did really well. And so we were not selected for the pitch competition, which we were a little bummed about because I killed the pitch,” Burkhardt recalls.

But Phiogen is worthy of note, pitch competition or not. The new company spun off from research at Dr. Anthony Maresso’s TAILOR Labs, a personalized phage therapy center at Baylor College of Medicine, last June.

“Our whole goal is to create the next generation of anti-infectives,” says Burkhardt.

That means that the company is making alternatives to antibiotics, but as Burkhardt says, “We’re hoping to be better than antibiotics.”

How does it work? Bacteriophages are viruses that infect bacteria.

“You can imagine them as the predators in the bacteria world, but they don't infect humans. They don't affect animals. They only infect bacteria,” Burkhardt explains.

Phiogen utilizes carefully honed bacteriophages to attack bacteria that include the baddies behind urinary tract infection (UTI), bacteremia (bacteria in the blood), and skin wounds.

The team’s primary focus is on treatment-resistant UTI. One example was a male patient who received Phiogen’s treatment thanks to an emergency-use authorization from the FDA. The gentleman had been suffering from an infection for 20 years. He was treated with Phiogen’s bacteriophage therapy for two weeks and completely cleared his infection with no recurrence.

Amanda Burkhardt is the CEO of Phiogen. Photo via LinkedIn

But Phiogen has its sights set well beyond the first maladies it’s treated. An oft-quoted 2016 report projected that by 2050, 10 million people a year will be dying from drug-resistant infections.

“A lot of scientists call it the silent pandemic because it's happening now, we're living in it, but there's just not as much being said about it because it normally happens to people who are already in the hospital for something else, or it's a comorbidity, but that's not always the case, especially when we're talking about urinary tract infections,” says Burkhardt.

Bacteriophages are important because they can be quickly trained to fight against resistant strains, whereas it takes years and millions of dollars to develop new antibiotics. There are 13 clinical trials that are currently taking place for bacteriophage therapy. Burkhardt estimates that the treatment method will likely gain FDA approval in the next five years.

“The FDA actually has been super flexible on progressing forward. Because they are naturally occurring, there's not really a safety risk with these products,” she says.

And Burkhardt, whose background is in life-science commercialization, says there’s no better place to build Phiogen than in Houston.

“You have Boston, you have the Bay [Area], and you have the Gulf Coast,” she says. “And Houston is cheaper, the people are friendlier, and it’s not a bad place to be in the winter.”

She also mentions the impressive shadow that Helix Park will cast over the ecosystem. Phiogen will move later this year to the new campus — one of the labs selected to join Baylor College of Medicine.

And as for that prize, chances are, it won’t be Phiogen’s last.

Houston student selected for prestigious health care research program

bright future

A Houston-area undergraduate student has been tapped for a prestigious national program that pairs early-career investigators with health research professionals.

Mielad Ziaee was selected for the National Institutes of Health’s 2023-2024 All of Us Research Scholar Program, which connects young innovators with experts "working to advance the field of precision medicine," according to a statement from UH. Ziaee – a 20-year-old majoring in psychology and minoring in biology, medicine and society who plans to graduate in 2025 — plans to research how genomics, or the studying of a person's DNA, can be used to impact health.

“I’ll be one of the ones that define what this field of personalized, precision medicine will look like in the future,” Ziaee said in a statement. “It’s exciting and it’s a big responsibility that will involve engaging diverse populations and stakeholders from different systems – from researchers to health care providers to policymakers.”

Ziaee aims to become a physician who can use an understanding of social health conditions to guide his clinical practice. At a young age, he was inspired to go into the field by his family's own experience.

According to UH, Ziaee is the oldest child of Iranian American immigrants. He saw firsthand the challenges of how language and cultural barriers can impact patients' access to and level of care.

“I think a lot of people define health as purely biological, but a lot of other factors influence our well-being, such as mental health, financial health, and even access to good food, medical care and the internet,” he said in a statement. “I am interested in seeing the relationship among all these things and how they impact our health. So far, a lot of health policies and systems have not really looked beyond biology.”

"I want everyone to have an equal chance to access health care and take charge of their well-being. We need to have the systems in place that let people do that,” he added.

Ziaee is already on his way to helping Houston-based and national health systems and organizations make headway in this area.

He was named as a student regent on the UH System Board of Regents last year, sits on the board of the Houston chapter of the American Red Cross, and is an Albert Schweitzer Fellow.

Last year he was a Centers for Disease Control and Prevention John R. Lewis scholar, for which he presented his research project about predicting food insecurity in pediatric clinical settings and recommendations to improve the assessment based off his summer research with the Johns Hopkins University School of Medicine and the Kennedy Krieger Institute.

Prior to this, he completed a 10-week guided research experience using data visualization and predictive modeling techniques to assess food insecurity in the Third Ward.

“I just took every opportunity that came to me,” Ziaee said. “All my experiences connect with my central desire to increase health access and improve health care. I am very intentional about connecting the dots to my passion.”

Earlier this year, three UH student researchers were named among 16 other early-stage research projects at U.S. colleges and universities to receive a total of $17.4 million from the DOE's Office of Fossil Energy and Carbon Management (FECM). The projects were each awarded between about $750,000 to up to $1.5 million.

Houston tech entrepreneur expands energy data co. in Europe, continues to scale

houston innovators podcast episode 229

The technology that Amperon provides its customers — a comprehensive, AI-backed data analytics platform — is majorly key to the energy industry and the transition of the sector. But CEO Sean Kelly says he doesn't run his business like an energy company.

Kelly explains on the Houston Innovators Podcast that he chooses to run Amperon as a tech company when it comes to hiring and scaling.

"There are a lot of energy companies that do tech — they'll hire a large IT department, they'll outsource a bunch of things, and they'll try to undergo a product themselves because they think it should be IP," he says on the show. "A tech company means that at your core, you're trying to build the best and brightest technology."

To Kelly, Amperon should be hiring in the same field as Google and other big tech companies that sit at the top of the market. And Kelly has done a lot of hiring recently. Recently closing the company's $20 million series B round last fall led by Energize Capital, Amperon has tripled its team in the past 14 months.

With his growing team, Kelly also speaks to the importance of partnerships as the company scales. Earlier this month, Amperon announced that it is replatforming its AI-powered energy analytics technology onto Microsoft Azure. The partnership with the tech giant allows Amperon's energy sector clients to use Microsoft's analytics stack with Amperon data.

And there are more collaborations where that comes from.

"For Amperon, 2024 is the year of partnerships," Kelly says on the podcast. "I think you'll see partnership announcements here in the next couple of quarters."

Along with more partners, Amperon is entering an era of expansion, specifically in Europe, which Kelly says has taken place at a fast pace.

"Amperon will be live in a month in 25 countries," he says.

While Amperon's technology isn't energy transition specific, Kelly shares how it's been surprising how many clean tech and climate tech lists Amperon has made it on.

"We don't brand ourselves as a clean tech company," Kelly says, "but we have four of the top six or eight wind providers who have all invested in Amperon. So, there's something there."

Amperon, which originally founded in 2018 before relocating to Houston a couple of years ago, is providing technology that helps customers move toward a lower carbon future.

"If you look at our customer base, Amperon is the heart of the energy transition. And Houston is the heart of the energy transition," he says.

View All Listings